Enlivex ENLV
NASDAQ ENLV
$1.04 -0.07 (-6.31%)
At close: Sep 9, 2026 · 4:00 PM EDT

Enlivex (ENLV) Operating Expenses (2013 - 2025)

Enlivex (ENLV) posted Operating Expenses of $5.9 million for Q4 2025, up 129.21% on a QoQ basis from $2.6 million in Q3 2025, and up 6.93% year-over-year from $5.5 million in Q4 2024.

Analysis

Enlivex (ENLV) Operating Expenses (2013 - 2025) Analysis & Trends

Enlivex has reported Operating Expenses for 13 years, with the latest figure at $5.9 million in Q4 2025.

  • On a quarterly basis, Operating Expenses rose 6.93% year-over-year to $5.9 million in Q4 2025; TTM through Dec 2025 was $15.0 million, a 3.45% decrease from a year earlier, with the FY2025 full-year figure at $15.0 million, down 5.41% from the prior year.
  • Operating Expenses was $5.9 million for Q4 2025 at Enlivex, up from $2.6 million in the prior quarter.
  • The five-year high for Operating Expenses was $7.8 million in Q4 2022, with the low at $2.6 million in Q3 2025.
  • Average Operating Expenses over 5 years is $5.0 million, with a median of $5.6 million recorded in 2023.
  • The sharpest annual moves came in 2021 and 2024: Operating Expenses surged 111.36% in 2021, then tumbled 55.09% in 2024.
  • Over 5 years, Operating Expenses stood at $7.8 million in 2021, then climbed by 0.4% to $7.8 million in 2022, then declined by 22.36% to $6.1 million in 2023, then dropped by 10.01% to $5.5 million in 2024, then gained by 6.93% to $5.9 million in 2025.
  • The last three Operating Expenses figures came in at $5.9 million (Q4 2025), $2.6 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 367.83 Mn
10 Enlivex 3.17 Mn -2.59 Mn - 5.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.86 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 3.08 Mn
Mar 31, 2025 3.50 Mn
Dec 31, 2024 5.48 Mn
Sep 30, 2024 3.12 Mn
Jun 30, 2024 2.99 Mn
Mar 31, 2024 3.95 Mn
Dec 31, 2023 6.09 Mn
Sep 30, 2023 5.63 Mn
Jun 30, 2023 6.65 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 7.85 Mn
Sep 30, 2022 5.68 Mn
Jun 30, 2022 5.87 Mn
Mar 31, 2022 6.40 Mn
Dec 31, 2021 7.81 Mn
Sep 30, 2021 3.86 Mn
Jun 30, 2021 3.81 Mn
Mar 31, 2021 3.80 Mn